PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 95 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $864,000 | -38.0% | 102,328 | 0.0% | 0.05% | +11.1% |
Q1 2022 | $1,393,000 | -30.4% | 102,328 | +0.6% | 0.04% | -37.5% |
Q4 2021 | $2,001,000 | +91.3% | 101,728 | +212.3% | 0.07% | +125.0% |
Q3 2021 | $1,046,000 | -31.6% | 32,575 | -27.9% | 0.03% | -33.3% |
Q2 2021 | $1,530,000 | -36.1% | 45,211 | -29.1% | 0.05% | -29.4% |
Q1 2021 | $2,395,000 | +20.2% | 63,772 | +6.3% | 0.07% | -5.6% |
Q4 2020 | $1,993,000 | – | 60,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |